509.36

0.03% -0.13

After Hours: 509.36

Intuitive Surgical Inc (ISRG)

Overview News Price History Option Chain Financials Why ISRG Down? Discussions Forecast Stock Split

Intuitive Surgical Inc stock is traded at $509.36, with a volume of 2.83M. It is down -0.03% in the last 24 hours and down -8.58% over the past month. Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 9,500 da Vinci systems in hospitals worldwide, with more than 5,500 installations in the US and a growing number in emerging markets.

Previous Close:

$509.49

Open:

$514.7

24h Volume:

2.83M

Relative Volume:

1.44

Market Cap:

$189.82B

Revenue:

$8.71B

Net Income/Loss:

$2.48B

P/E Ratio:

74.69

EPS:

6.82

Net Cash Flow:

$1.75B

1W Performance:

-0.55%

1M Performance:

-8.58%

6M Performance:

-2.87%

1Y Performance:

+17.76%

1-Day Range:

$508.76

$515.01

1-Week Range:

$506.54

$523.53

52-Week Range:

$413.82

$616.00

Intuitive Surgical Inc Stock (ISRG) Company Profile

Name

Intuitive Surgical Inc

Sector

Healthcare (1174)

Industry

Medical Instruments & Supplies (61)

Phone

(408) 523-2100

Address

1020 KIFER ROAD, SUNNYVALE

Employee

15,638

Twitter

@IntuitiveSurg

Next Earnings Date

2025-04-22

Latest SEC Filings

ISRG's Discussions on Twitter

Compare ISRG with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ISRG Intuitive Surgical Inc	509.36	189.82B	8.71B	2.48B	1.75B	6.82
BDX Becton Dickinson Co	168.42	49.98B	20.87B	1.50B	2.59B	5.24
ALC Alcon Inc	85.40	44.00B	9.93B	1.12B	1.58B	2.25
RMD Resmed Inc	253.68	37.05B	5.02B	1.31B	1.56B	8.91
WST West Pharmaceutical Services Inc	215.82	16.36B	2.90B	467.20M	306.90M	6.37

Intuitive Surgical Inc Stock (ISRG) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jun-09-25	Downgrade	Deutsche Bank	Hold → Sell
Jun-05-25	Upgrade	Erste Group	Hold → Buy
Dec-02-24	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Aug-02-24	Upgrade	Redburn Atlantic	Neutral → Buy
Jul-10-24	Reiterated	Citigroup	Buy
May-30-24	Initiated	Goldman	Buy
Nov-17-23	Initiated	HSBC Securities	Buy
Jul-19-23	Initiated	Robert W. Baird	Outperform
Apr-19-23	Reiterated	BTIG Research	Buy
Apr-19-23	Reiterated	BofA Securities	Buy
Apr-19-23	Reiterated	Citigroup	Buy
Apr-19-23	Reiterated	Evercore ISI	In-line
Apr-19-23	Reiterated	JP Morgan	Overweight
Apr-19-23	Reiterated	Morgan Stanley	Equal-Weight
Apr-19-23	Reiterated	RBC Capital Mkts	Outperform
Apr-19-23	Reiterated	Raymond James	Outperform
Apr-19-23	Reiterated	Stifel	Buy
Apr-19-23	Reiterated	Truist	Buy
Apr-19-23	Reiterated	Wells Fargo	Overweight
Mar-29-23	Initiated	UBS	Neutral
Mar-23-23	Initiated	William Blair	Outperform
Oct-18-22	Initiated	Barclays	Overweight
Oct-13-22	Initiated	Mizuho	Neutral
Oct-12-22	Initiated	Jefferies	Hold
Apr-13-22	Initiated	Truist	Buy
Apr-06-22	Initiated	Wolfe Research	Peer Perform
Mar-25-22	Initiated	RBC Capital Mkts	Outperform
Mar-02-22	Resumed	BofA Securities	Buy
Feb-02-22	Upgrade	UBS	Neutral → Buy
Jan-31-22	Upgrade	Piper Sandler	Neutral → Overweight
Jan-25-22	Downgrade	Redburn	Buy → Neutral
Jan-21-22	Reiterated	BTIG Research	Buy
Jan-21-22	Upgrade	Citigroup	Neutral → Buy
Jan-21-22	Reiterated	Deutsche Bank	Hold
Jan-21-22	Reiterated	Evercore ISI	In-line
Jan-21-22	Reiterated	Morgan Stanley	Equal-Weight
Jan-21-22	Reiterated	Piper Sandler	Neutral
Jan-21-22	Reiterated	Raymond James	Outperform
Jan-21-22	Reiterated	Robert W. Baird	Outperform
Jan-21-22	Reiterated	Stifel	Buy
Jan-21-22	Reiterated	UBS	Neutral
Jan-21-22	Reiterated	Wells Fargo	Overweight
Jan-10-22	Upgrade	BTIG Research	Neutral → Buy
Oct-01-21	Downgrade	Citigroup	Buy → Neutral
Jul-21-21	Reiterated	BofA Securities	Neutral
Jul-21-21	Reiterated	Citigroup	Buy
Jul-21-21	Reiterated	JP Morgan	Overweight
Jul-21-21	Reiterated	Morgan Stanley	Equal-Weight
Jul-21-21	Reiterated	Piper Sandler	Neutral
Jul-21-21	Reiterated	SVB Leerink	Mkt Perform
Jul-21-21	Reiterated	Stifel	Buy
Jul-21-21	Reiterated	UBS	Neutral
Jul-21-21	Reiterated	Wells Fargo	Overweight
Jul-14-21	Reiterated	Goldman	Buy
Jun-01-21	Upgrade	Evercore ISI	Underperform → In-line
Apr-21-21	Upgrade	Oppenheimer	Underperform → Perform
Apr-21-21	Upgrade	Robert W. Baird	Neutral → Outperform
Apr-01-21	Initiated	Citigroup	Buy
Dec-15-20	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Sep-28-20	Initiated	Argus	Buy
Sep-11-20	Initiated	Wolfe Research	Outperform
Sep-08-20	Downgrade	BofA Securities	Buy → Neutral
Sep-02-20	Initiated	Robert W. Baird	Neutral
Jul-20-20	Reiterated	Bernstein	Outperform
Apr-28-20	Downgrade	Piper Sandler	Overweight → Neutral
Apr-17-20	Downgrade	CFRA	Hold → Sell
Apr-17-20	Downgrade	SVB Leerink	Outperform → Mkt Perform
Apr-09-20	Downgrade	Evercore ISI	In-line → Underperform
Apr-01-20	Downgrade	Oppenheimer	Perform → Underperform
Jan-27-20	Downgrade	Deutsche Bank	Buy → Hold
Dec-12-19	Reiterated	Wells Fargo	Outperform
Nov-21-19	Initiated	Oppenheimer	Perform
Jul-19-19	Reiterated	Canaccord Genuity	Buy
Apr-22-19	Reiterated	Canaccord Genuity	Buy
Apr-02-19	Initiated	Deutsche Bank	Buy
Oct-31-18	Reiterated	Piper Jaffray	Overweight
Oct-19-18	Upgrade	Canaccord Genuity	Hold → Buy

View All

Intuitive Surgical Inc Stock (ISRG) Latest News

Jun 18, 2025

ISRG vs BSX: Which Medical Device Stock Has More Room to Run? - The Globe and Mail

Jun 18, 2025

Virtual Incision Names Intuitive Veteran Jim Alecxih as CEO - Medical Product Outsourcing

Jun 18, 2025

Virtual Incision Appoints Jim Alecxih as Chief Executive Officer - Morningstar

Jun 18, 2025

Neurosurgery Surgical Robots Market Set to Witness Significant - openPR.com

Jun 18, 2025

Jun 17, 2025